[1]Churg J, Strauss L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951, 27:277-301. [2]Moore P, Toon LT: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) masquerading as acute coronary syndrome. Clin Med J (Lond). 2020, 20:s51. [3]Cottin V, Bel E, Bottero P, et al.: Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Eur Respir J. 2016, 48:1429-1441. [4]Durel CA, Berthiller J, Caboni S, Jayne D, Ninet J, Hot A: Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Arthritis Care Res. 2016, 68:374-387. [5]Mohammad AJ: An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford). 2020, 59:42-50. [6]Plumb LA, Oni L, Marks SD, Tullus K: Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management. Pediatr Nephrol. 2018, 33:25-39. [7]d'Ersu E, Ribi C, Monney P, et al.: Churg-Strauss syndrome with cardiac involvement: case illustration and contribution of CMR in the diagnosis and clinical follow-up. Int J Cardiol. 2018, 258:321-324. [8]Thiel J, Troilo A, Salzer U, et al.: Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: a 36-month follow-up analysis. J Allergy Clin Immunol Pract. 2017, 5:1556-1563. |
|
来自: 文吾cgr0qse8eo > 《待分类》